Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
5.14
-0.01 (-0.19%)
At close: Jan 16, 2026, 4:00 PM EST
5.14
0.00 (0.03%)
After-hours: Jan 16, 2026, 7:32 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $57.1 million as of January 16, 2026. Its market cap has increased by 74.88% in one year.
Market Cap
57.10M
Enterprise Value
36.27M
1-Year Change
74.88%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $57.10M, a decrease of -21.61%. That is a compound annual growth rate of -5.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 59.20M | 0.17% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |